Insider · CIK 0001942596
Stephen Bardin
Files at CALC (CalciMedica, Inc.). First filing Jun 3, 2025, latest Jun 26, 2025.
In brief
Stephen Bardin files SEC Form 4 as CFO at CALC (CalciMedica, Inc.). Since Jun 3, 2025, Stephen Bardin has reported 2 open-market buys worth $4,695 and 0 open-market sells worth $0, the latest filed on Jun 26, 2025.
A track record needs three past buys with six months of prices behind them; Stephen Bardin has 0, so none is measured yet.
The newest scored trade: bought $3,005 of CALC on Jun 26, 2025, filed Jun 26, 2025, scored 70 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CALC: CalciMedica, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | CalciMedica, Inc. | $3,005 2,000 shares | +200% | 0% from low-71% from high | |
| 38Weak | CalciMedica, Inc. | $1,690 1,000 shares | +3% | +16% from low-66% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 3, 2024 | ATAI ATAI LIFE SCIENCES N.V. | 9,333 0.01% of outstanding | $21k | May 3, 2024 | $419k |
| Apr 8, 2024 | ATAI ATAI Life Sciences N.V. | 16,777 0.01% of outstanding | $42k | Apr 8, 2024 | $377k |
| Apr 5, 2024 | ATAI ATAI Life Sciences N.V. | 6,423 0.00% of outstanding | $16k | Apr 5, 2024 | $361k |
| Apr 4, 2024 | ATAI ATAI Life Sciences N.V. | 639 0.00% of outstanding | $1,577 | Apr 4, 2024 | $340k |
| Apr 4, 2024 | ATAI ATAI Life Sciences N.V. | 7,100 0.00% of outstanding | $20k | Apr 4, 2024 | $340k |
| Apr 3, 2024 | ATAI ATAI Life Sciences N.V. | 107,046 0.06% of outstanding | $228k | Apr 3, 2024 | $112k |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | CALC CalciMedica, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +190,000 | $0.00 | $0 | 190,000 | 16 d ago |
| Apr 5, 2025 | CALC CalciMedica, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +67,728 | $0.00 | $0 | 67,728 | Apr 7, 2026 |
| Jun 26, 2025 | CALC CalciMedica, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +2,000 | $1.50 | $3,005 | 3,000 | Jun 26, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 26, 2025 |
| May 30, 2025 | CALC CalciMedica, Inc. | POpen-market purchase Common Stock | +1,000 | $1.69 | $1,690 | 41,000 | Jun 3, 2025 |
| Apr 23, 2025 | CALC CalciMedica, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +130,000 | $0.00 | $0 | 130,000 | Apr 25, 2025 |
Questions about Stephen Bardin
Answered from the filings on this page, as of the latest one.
Is Stephen Bardin buying or selling?
Not in the last 12 months. Stephen Bardin's latest open-market trade on SEC Form 4 was bought $3,005 of CALC on Jun 26, 2025.
How did Stephen Bardin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen Bardin has 0.
Where does Stephen Bardin file Form 4?
Stephen Bardin has filed Form 4 at CALC (CalciMedica, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.